Literature DB >> 18390811

Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets?

G Brabant1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390811     DOI: 10.1210/jc.2007-2228

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  14 in total

Review 1.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

2.  Current recommendations for levothyroxine treatment of differentiated thyroid cancer patients are not properly implemented in clinical practice.

Authors:  J F Martins de Almeida; W Gonçalves Tsumura; M Vaisman; L V Montalli Assumpção; L S Ward
Journal:  J Endocrinol Invest       Date:  2012-04-18       Impact factor: 4.256

3.  99Tc-Methylene Diphosphonate Treatment is Safe and Efficacious for Osteoporosis in Postmenopausal Differentiated Thyroid Cancer Patients Undergoing TSH Suppression: A Three-Center Non-Randomized Clinical Study.

Authors:  Jianhao Xie; XueYu Yuan; Weiqing Mao; Haidong Cai; Kejia Gao; Zhongwei Lv; Hui Wang; Chao Ma
Journal:  Cancer Manag Res       Date:  2022-03-05       Impact factor: 3.989

4.  Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre.

Authors:  Elaine Lam; Scott S Strugnell; Chris Bajdik; Daniel Holmes; Sam M Wiseman
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

5.  A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.

Authors:  Juan P Brito; Yasuhiro Ito; Akira Miyauchi; R Michael Tuttle
Journal:  Thyroid       Date:  2015-11-05       Impact factor: 6.568

6.  The effect of long-term thyroid-stimulating hormone suppressive therapy on the gonadal steroid hormones of patients with thyroid carcinoma after surgery.

Authors:  Xiaoli Liu; Ying Zhou; Nan Liang; Yang Hong; Gianlorenzo Dionigi; Hui Sun
Journal:  Gland Surg       Date:  2017-10

7.  Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.

Authors:  Georgios Kostopoulos; Ioannis Doundoulakis; Christina Antza; Emmanouil Bouras; Krishnarajah Nirantharakumar; Dimitrios Tsiachris; G Neil Thomas; Gregory Y H Lip; Konstantinos A Toulis
Journal:  Endocr Relat Cancer       Date:  2021-04-29       Impact factor: 5.678

Review 8.  Radioiodine Remnant Ablation: A Critical Review.

Authors:  Chandra Sekhar Bal; Ajit Kumar Padhy
Journal:  World J Nucl Med       Date:  2015 Sep-Dec

Review 9.  Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer.

Authors:  Zeina C Hannoush; Roy E Weiss
Journal:  Rambam Maimonides Med J       Date:  2016-01-28

10.  An overall and dose-response meta-analysis for thyrotropin and thyroid cancer risk by histological type.

Authors:  Na Hu; Zhan-Ming Li; Jin-Feng Liu; Zhen-Zhen Zhang; Li-Shun Wang
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.